Abstract
Article AbstractBecause this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.To the Editor: Dialogue on the design, conduct, analysis, and reporting of comparative effectiveness research is important for formulating valid treatment guidance and ensuring effective and efficient health care resource utilization. The analysis by Barnett et al assessed the cost-effectiveness of long-acting injectable (LAI) risperidone versus physician's choice of oral antipsychotics in Veterans Health Administration patients with unstable schizophrenia or schizoaffective disorder. The study on which this analysis was based (Rosenheck et al) was partly funded by our company. We fully support research characterizing our products†efficacy, safety, appropriate use, and cost-effectiveness.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
